(NASDAQ: TLPH) Talphera's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 13.74%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.67%.
Talphera's earnings in 2026 is -$14,290,000.On average, 4 Wall Street analysts forecast TLPH's earnings for 2026 to be -$15,570,500, with the lowest TLPH earnings forecast at -$17,167,090, and the highest TLPH earnings forecast at -$13,663,602. On average, 4 Wall Street analysts forecast TLPH's earnings for 2027 to be -$15,570,500, with the lowest TLPH earnings forecast at -$17,167,090, and the highest TLPH earnings forecast at -$13,663,602.
In 2028, TLPH is forecast to generate -$9,699,656 in earnings, with the lowest earnings forecast at -$9,809,766 and the highest earnings forecast at -$9,459,417.